Role of Endogenous Murine Leukemia Virus in Immunologically Triggered Lymphoreticular Tumors. I. Development and Use of Oncogenic Cellfree Preparations Serially Passaged In Vivo2
Armstrong M, Ruddle N, Lipman M, Pierce S, Richards F. Role of Endogenous Murine Leukemia Virus in Immunologically Triggered Lymphoreticular Tumors. I. Development and Use of Oncogenic Cellfree Preparations Serially Passaged In Vivo2. Journal Of The National Cancer Institute 1977, 58: 67-72. PMID: 13227, DOI: 10.1093/jnci/58.1.67.Peer-Reviewed Original ResearchConceptsLymphoreticular tumorsB-tropic MuLVSyngeneic miceBALB/Reticular tissueMurine leukemia virusYoung adult recipientsLatent periodNormal control miceLeukemia virusEndogenous murine leukemia virusMean latent periodImmunologic disturbancesAdult recipientsControl miceMuLV replicationHost reactionGVHRTumorsMiceB-tropic murine leukemia virusSerial passageCellfree extractsMuLVVirus